GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic peptide agonists have several mechanisms of action, including reduction of gastric emptying, inhibition of glucagon secretion, beneficial changes in the intestinal microbiome, and direct effects on hypothalamic nuclei to enhance satiety (which promotes weight loss)
Others worry about wasting a partly used pen
What are GLP-1 medications GLP-1 medications, like Semaglutide and Tirzepatide, are FDA-approved treatments designed to regulate appetite, slow digestion, and improve blood sugar levels
This provides patients with the confidence that they are using a safe and effective treatment supported by science
Pre-existing diabetes does not disqualify you
Common loading doses in research contexts start at 0.25mg and are gradually increased